Article

Effect of systemic glucocorticoid immunosuppression timing, dose, and duration on overall survival among immune checkpoint inhibitor recipients: a retrospective multicohort study

2025-06-23

Abstract excerpt

<h4>Summary</h4> <h4>Background</h4> Systemic immunosuppression (sISP), particularly with glucocorticoids, is commonly used among patients receiving immune checkpoint inhibitor (ICI) therapy. Although recent studies have demonstrated that sISP is associated with poor outcomes in ICI recipients, there is limited information on how the timing, dose, and duration of sISP affect overall survival (OS). This multi-coh...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f80b792f-e0ae-5f10-98c5-dd2d4f0608e1
DOI: 10.1101/2025.06.23.25330022

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Effect of systemic glucocorticoid immunosuppression timing, dose, and duration on overall survival among immune checkpoint inhibitor recipients: a retrospective multicohort studyDOI 10.1101/2025.06.23.25330022Read

Long-term mortality outcomes among immunotherapy recipients treated with dupilumab for the management of cutaneous immune-related adverse eventsSemantic proximity Read

Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse eventsSemantic proximity Read

Severity and organ distribution of graft-versus-host disease with post-transplant cyclophosphamide versus calcineurin inhibitor plus methotrexate/mycophenolate mofetil or sirolimus in allogenic HLA-matched or single-allele mismatched stem cell transplantation.Semantic proximity Read

Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host DiseaseSemantic proximity Read

Clinical Characteristics and Human Leukocyte Antigens in patients with Immune Checkpoint Inhibitor-induced Type 1 Diabetes and Pituitary Dysfunction: A single center prospective studySemantic proximity Read

Efficacy and safety of a triple combination of glucocorticoids, tofacitinib and calcineurin inhibitors in anti-MDA5 positive dermatomyositisSemantic proximity Read

Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridgingSemantic proximity Read

Is earlier always better? Timing of antifibrotic therapy and overall survival in idiopathic pulmonary fibrosis: a multicenter retrospective studySemantic proximity Read

Analysis of Antibiotic Exposure and Development of Acute Graft-vs-Host Disease Following Allogeneic Hematopoietic Cell TransplantationSemantic proximity Read

Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host DiseaseSemantic proximity Read

Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II study.Semantic proximity Read